Nanocage targets drug site bullseye; Supersized vaccine plant;

> A smart nanocage made of gold and covered with a smart polymer is light-activated to release its medicinal contents--a chemotherapy drug or bactericide, for example--only near the target tissue. Article

> Toronto-based Microbix Biosystems (MBX:TSX) and joint-venture partner Hunan Biopharmaceutical will build what they call "the world's third largest influenza vaccine facility." Announcement

> Russian drugmaker Materia Medica has again turned to contract manufacturer Angel Biotechnology (ABH.L), this time for process development and GMP manufacturing of certain antibodies. Release

> The Royal Pharmaceutical Society has joined forces with Pfizer to launch part two of the manufacturers' anti-counterfeiting campaign. Article

> The Motley Fool provides its unique insights in a face-off of the big three pharma industry distributors. Analysis

Suggested Articles

Lonza CEO Marc Funk is leaving for "personal reasons" after less than a year in the top job. 

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.